LYMPHOPROLIFERATIVE DISEASES: PATHOGENESIS, DIAGNOSIS, THERAPY

Important note: Information in this article was accurate in 1986. The state of the art may have changed since the publication date.

LYMPHOPROLIFERATIVE DISEASES: PATHOGENESIS, DIAGNOSIS, THERAPY

Dev Oncol; 31:1-207 1985. Unique Identifier : AIDSLINE ICDB/86624698
Anonymous; No affiliation given

Abstract: This book consists of the proceedings of a symposium on lymphoproliferative diseases, held at the University of Southern California, Los Angeles, November 16-17, 1984. The articles are divided into four sections, namely, pathobiology, epidemiology, diagnosis, and clinical aspects. Those included in the first section have the following titles: oncogene activation by chromosomal translocations; molecular analysis of the human interleukin-2 receptor; DNA rearrangements as unique molecular markers of clonality, cellular lineage, differentiation, and translocation; animal models of lymphoid cell neoplasia; and a new look at the relationship of the immune system to neoplasia. The topics included in the second section have the titles: the epidemiology of lymphomas; and clinico-epidemiological features of adult T-cell leukemia/lymphoma (ATLL) in Japan: relations of HTLV-I/ATLV infection to ATLL manifestation. The third section has the following titles: immunohistologic techniques: their impact in tumor diagnosis, with particular reference to lymphomas; serologic approaches to tumor diagnosis; use of radio-labeled antibodies in diagnosis and staging of solid tumors; and flow cytometry in lymphoma/leukemia diagnosis. Finally, in the fourth section the titles are: changing concepts in therapy of the non-Hodgkin lymphomas; biological approaches to the therapy of lymphoproliferative diseases; a comparison of the acquired immune deficiency syndrome in monkey and man; and human T-lymphotropic retrovirus (HTLV-III)-associated lymphoproliferative disorders in homosexual men.

Keywords: Animal Human Lymphoproliferative Disorders/*DIAGNOSIS/ETIOLOGY/THERAPY MONOGRAPH

861130
M86B0240

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1986. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1986. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .